ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report included.

November 5, 2004

NCI CTEP-Approved Trials For the Month of February

February 28, 2014

Toxicology Program Board To Review Nine Substances.

January 14, 2000

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

Fadlo Khuri Named Editor-in-Chief Of ACS Journal Cancer

August 12, 2011

Kimes: Centers Need New $$ Sources; Fox Chase, U.Pa Go Seperate Ways

October 12, 1990